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 Introduction 
 The target of rapamycin (TOR) and insulin signaling pathways 
control cell growth, proliferation, and metabolism throughout 
organism development and adult homeostasis. The TOR path-
way is an ancient signaling network conserved from yeast to 
humans that responds to environmental stimuli, such as nutrient 
and oxygen availability, as well as growth factor signaling (for 
reviews see  Oldham and Hafen, 2003 ;  Wullschleger et al., 2006 ). 
The insulin pathway evolved in metazoans to enable dynamic 
control of cell growth, proliferation, and metabolism in a systemic 
fashion. Multiple points of crosstalk exist between the insulin 
and TOR pathways, which ensure optimal activity of each path-
way and hence allow adjustment to dynamic environmental and 
dietary conditions. For example, in response to hyperactivation 
of the TOR pathway by conditions such as high levels of amino 
acids, glucose, or free fatty acids or, genetically, by mutation of 
 tuberous sclerosis complex (Tsc)1 or  Tsc2 , insulin signaling is 
suppressed (for review see  Manning, 2004 ). Altered activity of 
multiple components of the insulin and TOR pathways, such as 
phosphoinositide 3-kinase, Akt, PTEN, TSC1, and TSC2 con-
tribute to an array of human cancers (for reviews see  Luo et al., 
2003 ;  Inoki et al., 2005 ). 
 Akt is an important insulin pathway protein that promotes 
cell growth, proliferation, and survival by phosphorylating mul-
tiple effector proteins, including the TOR pathway inhibitor 
TSC2 and FOXO family transcription factors (for reviews see 
 Manning, 2004 ;  Greer and Brunet, 2005 ;  Wullschleger et al., 
2006 ). FOXO transcription factors have well-defi ned roles in 
insulin-dependent control of longevity and metabolism as well as 
stress resistance (for reviews see  Greer and Brunet, 2005 ;  Kenyon, 
2005 ). These proteins have also been implicated in insulin-
dependent control of tissue growth but their role in this process 
is more controversial. FOXO proteins have been shown to re-
strict tumor formation in mice ( Paik et al., 2007 ). Surprisingly, 
 Drosophila melanogaster mutants for the gene encoding the 
sole FOXO family transcription factor develop normally and 
are of normal size, which brings into question the role of FOXO 
in the developmental regulation of growth under normal circum-
stances ( Junger et al., 2003 ). 
 FOXO has been shown to attenuate growth of  D. melano-
gaster tissues with elevated TOR pathway activity ( Junger et al., 
2003 ). Here, we further characterize this phenomenon by showing 
that  Tsc1 mutations cause increased FOXO levels, resulting in 
elevated expression of FOXO-regulated genes, some of which 
 FOXO is thought to function as a repressor of growth that is, in turn, inhibited by insulin signaling. How-ever, inactivating mutations in  Drosophila melano-
gaster FOXO result in viable fl ies of normal size, which 
raises a question over the involvement of FOXO in growth 
regulation. Previously, a growth-suppressive role for 
FOXO under conditions of increased target of rapamycin 
(TOR) pathway activity was described. Here, we further 
characterize this phenomenon. We show that  tuberous 
sclerosis complex 1 mutations cause increased FOXO levels, 
resulting in elevated expression of FOXO-regulated genes, 
some of which are known to antagonize growth-promoting 
pathways. Analogous transcriptional changes are observed 
in mammalian cells, which implies that FOXO attenuates 
TOR-driven growth in diverse species.
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important activity-modulating feature of many signaling path-
ways, including the TOR and insulin pathways (for review see 
 Manning, 2004 ). 
 Tsc1 loss-of-function (LOF) and FOXO 
gain-of-function (GOF) transcription 
profi les are overlapping 
 To examine the mechanism whereby transcription of growth in-
hibitors is induced in response to TOR hyperactivation, we sought 
to determine which transcription factors were responsible for 
their expression. One obvious candidate was FOXO, a member 
of the forkhead transcription factor family, which has a well-
established role as an effector of insulin signaling (for review 
see  Greer and Brunet, 2005 ). If FOXO has a role in inducing 
expression of negative regulators of growth in  Tsc tissue, then 
expression of some of those genes should be elevated under 
conditions of increased FOXO activity. To investigate this 
hypothesis, we compared the expression profi les of  Tsc1 LOF 
tissue and  D. melanogaster  S2 cells expressing FOXOA3, a mu-
tant version of FOXO that is insensitive to phosphorylation-
dependent inhibition by Akt ( FOXO GOF;  Puig et al., 2003 ; 
 Gershman et al., 2007 ). This analysis revealed that 25 genes 
were up-regulated 1.5-fold or greater in both  Tsc1 LOF and 
 FOXO GOF expression profi les, which represents a highly sig-
nifi cant degree of overlap (P = 4.9  × 10 e  009 ) as determined by 
calculation of the hypergeometric distribution. This highly sta-
tistically signifi cant P value strongly suggests that there is a func-
tional overlap between these two datasets that cannot be explained 
by random variation. Genes that were elevated at least 1.5-fold 
(P  < 0.05) in both  Tsc1 LOF and  FOXO GOF cells and that have 
are known to antagonize growth-promoting pathways. In addition 
we show that this FOXO-dependent transcriptional response is 
conserved in mammals. 
 Results and discussion 
 Genes encoding growth inhibitors are 
elevated in Tsc1 tissue 
 To investigate mechanisms by which the TOR pathway controls 
tissue growth, we analyzed transcriptional profi les of tissue lack-
ing  Tsc1 , which leads to hyperactivation of the TOR pathway 
and excessive growth ( Gao and Pan, 2001 ;  Potter et al., 2001 ; 
 Tapon et al., 2001 ). Eye-antennal imaginal discs from third in-
star  D. melanogaster larvae were generated that were composed 
almost entirely of tissue derived from one of two different geno-
types:  Tsc1 or wild-type isogenic control. Three biologically 
independent fi rst strand cDNA samples from each genotype 
were hybridized to Affymetrix microarray chips. Expression 
levels of 157 genes were elevated 1.5-fold or more, whereas 211 
genes were repressed 1.5-fold or more (P  < 0.05) when com-
pared with control tissue. These genes have been implicated 
in diverse cellular functions including metabolism, membrane 
transport, stress response, cell growth, and cell structure ( Figs. 1 
and S1 and Tables S1 and S2, available at http://www.jcb.org/
cgi/content/full/jcb.200710100/DC1). 
 Observed transcriptional changes were validated for several 
genes using  D. melanogaster gene-enhancer trap lines ( Fig. 1, 
B – E ), and quantitative real-time PCR (QPCR; Fig. S2, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200710100/DC1). 
The UAS – Gal4 system was used to activate the TOR pathway 
in a specifi c tissue domain by driving expression of  Rheb under 
the control of the  glass multiple reporter ( GMR ) promoter. 
 Induction of  astray ( aay) and  4E-BP (both of which were found 
to be elevated in  Tsc1 tissue by microarray analysis) were ob-
served in the  GMR  expression domain (posterior to the morpho-
genetic furrow) when  Rheb was misexpressed but were not 
induced when the negative control  Gal4 gene was misexpressed 
( Fig. 1, B – E ). QPCR was also used to confi rm expression changes 
observed in  Tsc1 tissue for  charybdis (chrb) , scylla (scy) , phos-
phoenolpyruvate carboxy kinase , 4E-BP , and  aay (Fig. S2). 
 Intriguingly, several gene products whose expression was 
elevated in  Tsc1 tissue have been implicated in tissue growth 
controlled by the insulin and TOR pathways, including 4E-BP, 
Chrb, and Scy ( Miron et al., 2001 ;  Reiling and Hafen, 2004 ). 
4E-BP is a repressor of cap-dependent translation. Upon 
phosphory lation by TOR, 4E-BP dissociates from eIF4e, allow-
ing assembly of the initiation complex at the mRNA cap structure, 
ribosome recruitment, and subsequent translation (for review 
see  Wullschleger et al., 2006 ). Scy and Chrb, and their mamma-
lian orthologues REDD1 and REDD2, inhibit insulin and TOR 
signaling in response to hypoxia and energy stress and restrict 
growth during  D. melanogaster development ( Brugarolas et al., 
2004 ;  Reiling and Hafen, 2004 ;  Sofer et al., 2005 ). Our fi nding 
that inhibitors of growth are highly expressed in  Tsc1 tissue led 
us to hypothesize that such genes are transcriptionally induced 
as part of a feedback loop that restricts tissue growth under 
conditions of excessive TOR activity. Feedback loops are an 
 Figure 1.  Genes elevated in developing  Tsc1 eye-antennal tissue. (A) Tran-
scriptional changes observed in  Tsc1 eye-antennal imaginal discs grouped 
by proposed biological function. Included are genes whose expression 
was elevated at least 1.5-fold (P  < 0.05) in  Tsc1 tissue compared with the 
wild type. (B – E) Third instar larval eye imaginal discs; anterior is shown on 
the right. Arrowheads indicate the morphogenetic furrow. Activity of  aay 
(B and C) and  4e-bp (D and E) enhancer trap lines in tissue misexpressing 
 Gal4 (B and D) or  Rheb (C and E) under control of the  GMR promoter. 
Bar, 50   M. 
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explanation is that our  scy – promoter construct lacked the mini-
mal promoter elements required for transcription of  luciferase . 
 FOXO protein is elevated and active in 
Tsc1 tissue 
 TOR pathway hyperactivation caused by  Tsc defi ciency has 
been shown to strongly repress activity of Akt ( Radimerski 
et al., 2002 ). FOXO is normally inactivated by Akt-dependent 
phosphorylation, which restricts nuclear entry of FOXO and 
leads to its ubiquitin-dependent destruction (for review see  Greer 
and Brunet, 2005 ). Therefore, in response to TOR pathway hyper-
activation, we predicted that reduced Akt activity would cause 
FOXO protein to accumulate. To examine this hypothesis, we 
analyzed expression of FOXO protein in mosaic  Tsc1 imaginal 
discs. We found that FOXO protein was markedly increased in 
 Tsc1 clones when compared with neighboring wild-type tissue 
( Fig. 4, A and B ). In addition, FOXO protein appeared to be 
mostly nuclear in  Tsc1 tissue and cytoplasmic in wild-type tis-
sue (Fig. S3, available at http://www.jcb.org/cgi/content/full/
jcb.200710100/DC1). Consistent with this observation, nuclear 
localization of the mouse FOXO orthologue FOXO1 was ob-
served in endothelial cells of  Tsc2 mutant hemangiomas, whereas 
FOXO1 was mostly cytoplasmic in normal cells ( Manning et al., 
2005 ).  FOXO mRNA levels were unchanged in  Tsc1 tissue as 
determined by microarray analysis, which suggests that changes 
in translation or stability of FOXO protein account for its accu-
mulation in  Tsc1 tissue. The presence of increased FOXO pro-
tein in the nuclei of  Tsc1 cells is consistent with our hypothesis 
that FOXO is responsible for increased expression of some of 
the growth inhibitors that are up-regulated in  Tsc1 cells. 
 To determine whether FOXO was necessary for transcrip-
tional induction of genes that were elevated in  Tsc1 tissue, we 
used QPCR analysis to measure  4E-BP , aay , and scy expression in 
 Tsc1 and  Tsc1-FOXO double mutant eye-antennal imaginal discs. 
Consistent with our microarray analysis, we observed  increased 
been assigned to certain cellular functions are shown in  Fig. 2 . 
Interestingly, two genes previously implicated in tissue growth 
regulated by the insulin and TOR pathways  4E-BP and  scy 
were elevated in both microarray experiments, whereas the  chrb 
growth-inhibiting gene was not ( Fig. 2 ). Thus, a subset of genes 
elevated in  Tsc1 tissue appears to respond to FOXO activity and 
was investigated further. 
 FOXO activates transcription of genes 
whose expression is elevated in Tsc1 tissue 
 4E-BP is a well-characterized FOXO target gene ( Junger et al., 
2003 ;  Puig et al., 2003 ). To determine whether FOXO could di-
rectly activate transcription of genes that were elevated in  Tsc1 
tissue other than  4E-BP , we focused on  scy and the phospho-
serine phosphatase  aay (one of the most highly elevated tran-
scripts in each microarray experiment).  scy and  aay both possess 
consensus FOXO recognition elements (FREs) in their pro-
moters comparable to those found in  dInR and  4E-BP promoters 
( Furuyama et al., 2000 ;  Puig et al., 2003 ). Therefore, we exam-
ined whether these genes are bona fi de FOXO targets by measur-
ing their expression in  D. melanogaster S2 cells misexpressing 
FOXOA3 in the presence of insulin ( Puig et al., 2003 ).  aay and 
 scy mRNAs were up-regulated 19.4- and 4.3-fold, respectively, 
relative to a control gene,  actin , as determined by QPCR ( Fig. 3 B ). 
Next, we used luciferase reporter assays in S2 cells to determine 
whether the  aay promoter region containing putative FREs was 
sensitive to FOXO activity. As shown in  Fig. 3 C , luciferase ac-
tivity dependent on the  aay promoter was strongly induced by 
FOXOA3 relative to a negative control. In addition, using in vitro 
band shift assays, we demonstrated that FOXO directly bound to 
the  aay promoter ( Fig. 3 D ), which indicates that FOXO 
likely activates expression of  aay by directly binding to the FRE. 
Surprisingly, in parallel luciferase reporter assays, we could not 
demonstrate activation of the  scy promoter by FOXO, despite 
the fact that we observed strong binding of FOXO to the putative 
 scy FRE using in vitro band-shift assays ( Fig. 3 E ). A possible 
 Figure 2.  Common transcriptional changes in  Tsc1 tissue and cells mis-
expressing  FOXO . Genes elevated at least 1.5-fold (P  < 0.05) in both  Tsc1 eye-
antennal disc tissue and S2 cells misexpressing activated  FOXO . Genes with 
a proposed biological function are listed as well as their expression level as 
determined by microarray analysis in each experimental condition. 
 Figure 3.  FOXO can directly induce expression of genes elevated in  Tsc1 
tissue. (A) Schematic representation of FREs in  aay and  scy promoters. 
(B) QPCR analysis of  aay and  scy mRNA in S2 cells transfected with wild-
type FOXO (W) or FOXO GOF (A3) in the presence of insulin ( n  = 3). 
(C) Luciferase assay ( n  = 4) measuring transcriptional activity of the  aay 
promoter in S2 cells expressing either vector alone (con) or FOXOA3 (FOXO). 
(D and E) Band shift assays examining the ability of increasing amounts of 
FOXO to complex with the  aay promoter (D),  scy promoter (E), or negative 
control DNA fragments. DNA markers are indicated in bp. Error bars in 
B and C represent standard deviation. 
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( Treins et al., 2002 ;  Dekanty et al., 2005 ) and drives transcription 
of the growth-inhibiting genes  scy and  chrb ( Reiling and Hafen, 
2004 ), both of which we found to be elevated in  Tsc1 tissue. 
 D. melanogaster possesses several HIF-1  subunits and a 
sole HIF-1  subunit,  tango ( tgo ), which partners with each 
HIF-1  subunit. If FOXO and/or HIF-1 are required to induce 
expression of genes that limit tissue growth when the TOR path-
way is hyperactivated, one might predict that  Tsc1-FOXO and/or 
 Tsc1-tgo double mutant tissue would possess a greater capacity 
to grow than  Tsc1 tissue alone. To test this hypothesis, we ex-
amined the size of  D. melanogaster eyes comprised almost en-
tirely of the following genotypes: control,  tgo ,  FOXO ,  Tsc1 , 
 Tsc1-tgo , and  Tsc1-FOXO . Mutant eyes were created by driving 
mitotic recombination of chromosomes bearing fl ipase recogni-
tion target (FRT) sites and the appropriate gene mutations, spe-
cifi cally in developing  D. melanogaster eye-antennal imaginal 
discs. Eyes lacking either  tgo or  FOXO were approximately the 
same size as control eyes (not depicted), whereas  Tsc1 eyes 
were considerably larger ( Fig. 4, D and E ).  Tsc1-tgo double mu-
tant eyes did not exhibit a further increase in size, which sug-
gests that HIF-1 is not required to inhibit tissue growth in response 
to  Tsc1 loss ( Fig. 4 F ). In contrast,  Tsc1-FOXO double mutant 
eyes were substantially larger than  Tsc1 eyes, which is consistent 
with a previous study ( Fig. 4 G ;  Junger et al., 2003 ). This fi nding 
is particularly signifi cant in light of the fi nding that eyes lacking 
 FOXO were indistinguishable in size from wild-type eyes (un-
published data;  Junger et al., 2003 ). Thus, it appears that  FOXO 
is normally dispensable for control of eye size, but when growth 
control is altered by virtue of increased TOR activity,  FOXO 
partially offsets the increased tissue growth. These fi ndings are 
consistent with our observations that FOXO protein accumulates 
in  Tsc1 tissue and that transcriptional profi les of  FOXO GOF 
and  Tsc1 LOF cells overlap signifi cantly. 
 Transcriptional changes in cells with 
increased TOR activity are conserved 
in eukaryotes 
 Because individual components of the insulin and TOR path-
ways are highly conserved among eukaryotes, important regu-
latory mechanisms that control tissue growth via these pathways 
are also likely to be conserved. To investigate this idea, we ana-
lyzed transcriptional control of mouse orthologues of genes that 
were elevated in  D. melanogaster Tsc1 tissue. Initially, we per-
formed Northern blotting analysis on  Tsc2 primary mouse embry-
onic fi broblasts (MEFs; derived on a  p53 background to over come 
premature senescence induced by  Tsc2 loss;  Zhang et al., 2003 ). 
It is reasonable to predict that transcriptional changes that occur 
because of loss of either  Tsc1 or  Tsc2 should be very similar be-
cause TSC1 and TSC2 function together in an obligate fashion, 
and mutation of either gene leads to almost indistinguishable pheno-
types ( Tapon et al., 2001 ). We found that several gene expression 
changes observed in  D. melanogaster Tsc1 tissue were conserved 
in  Tsc2 MEFs ( Fig. 5 A ). The homologues of  aay , heat shock 
protein ( hsp) 23 ,  scy , and  chrb ( PSPH , hsp 27 ,  REDD1 , and 
 REDD2 , respectively) were all signifi cantly up-regulated in  Tsc2 
MEFs when compared with control MEFs and expression of the 
 glyceraldehyde-3-phosphate dehydrogenase ( GAPDH ) control. 
expression of  4E-BP , aay , and scy in  Tsc1 tissue ( Fig. 4 C ). 
In  Tsc1-FOXO tissue, however,  4E-BP was expressed at approx-
imately equivalent amounts as in wild-type tissue, whereas 
 aay and  scy expression was only partially reduced ( Fig. 4 C ). 
This demonstrates that elevated expression of  4E-BP in  Tsc1 
tissue is dependent on the FOXO transcription factor and pro-
vides evidence that FOXO activity increases when the TOR 
pathway is hyperactivated. Expression of  aay and  scy appear to 
be partially dependent on FOXO but are likely stimulated by 
additional transcription factors in  Tsc1 tissue. 
 FOXO but not hypoxia-inducible factor-1 
(HIF-1) inhibits growth in Tsc1-
defi cient tissues 
 Next, we sought to determine whether FOXO was required to 
limit growth of tissues with increased TOR pathway activity. 
In addition, we analyzed a potential role for another transcrip-
tion factor, HIF-1, for retardation of TOR-driven growth. HIF-1 
is a dual-subunit transcription factor consisting of   and   
subunits that functions in response to insulin/TOR signaling 
 Figure 4.  FOXO is elevated in  Tsc1 tissue and inhibits growth of  Tsc1 
organs. (A and B) Confocal microscope images of a  Tsc1 mosaic wing 
imaginal disc. FOXO expression (red in A and in the merged image shown 
in B) was elevated in  Tsc1 clones when compared with wild-type tissue, 
which expresses GFP (green in B). (C) QPCR analysis of  4e-bp , aay , and  scy 
mRNAs normalized to a  tubulin  ( tub ) control mRNA in eye-antennal imaginal 
disc tissue of several genotypes:  wild-type  ( wt ), Tsc1 , or  Tsc1-FOXO  ( T-F ). 
(D – G) Scanning electron micrographs of adult eyes of genotypes: wild 
type  (D and D  ),  Tsc1 (E and E  ),  Tsc1-tgo (F and F  ), and  Tsc1-FOXO 
(G and G ’ ). Data are represented as a mean expression level derived 
from between three and nine replicate experiments performed on pooled 
biological samples collected from at least 20 animals of each genotype. 
However,  n was still equal to 1. Therefore, data were averaged to pro-
vide mean expression data but did not allow measurement of error val-
ues such as standard deviation or standard error of the mean. Bars: 
(A and B) 50   M; (D – G) 100   M. 
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Thus, although the requirement for FOXO in restricting growth 
under normal development conditions appears dispensable, this is 
no longer the case under conditions of excessive TOR activation. 
These fi ndings have important implications for cancer syndromes 
that arise because of inappropriate TOR pathway activation, such 
as the human hamartomatous syndrome, tuberous sclerosis. 
TOR-dependent feedback inhibition is thought to contribute to 
the benign nature of  Tsc1 and  Tsc2 tumors ( Ma et al., 2005 ; 
 Manning et al., 2005 ). Conceivably, inactivating mutations in 
 FOXO family transcription factors and/or FOXO target genes 
that possess growth-inhibiting properties could promote further 
growth in normally benign  Tsc1 and  Tsc2 tumors. 
 Materials and methods 
 D. melanogaster stocks 
 The following stocks were used:  w; FRT82B ,  w; FRT82B Tsc1 Q87X ( Tapon 
et al., 2001 ),  w; FRT82B FOXO 25 (provided by E. Hafen, Institute of 
Molecular Systems Biology, Z ü rich, Switzerland;  Junger et al., 2003 ), 
 w; FRT82B Tsc1 Q87X , FOXO 25 (generated by meiotic recombination), 
 w; FRT82B tgo 5 (provided by S. Crews, University of North Carolina, Chapel 
Hill, NC;  Emmons et al., 1999 ),  w; FRT82B Tsc1 Q87X , tgo 5 (generated by 
meiotic recombination),  y w eyFlp; FRT82B P[W+] l(3)cl-R3 , y w hsFlp; 
FRT82B P(W + ubi-GFP) , y w; P(lacW)aay , y w; P(lacW)Thor , UAS-Rheb 
(provided by P. Patel, University of California, Los Angeles, Los Angeles, 
CA;  Patel et al., 2003 ), and  GMR-Gal4. 
 Microarray hybridization and analysis 
 Male fl ies of genotype  w; FRT82B or  w; FRT82B Tsc1 Q87X were crossed to 
 y w eyFlp; FRT82B P(W+) l(3)cl-R3 . Larval progeny from these crosses bore 
eye discs comprised almost entirely of one genotype (either wild-type or  Tsc1 ). 
Eye-antennal discs from third instar larvae of each genotype were dissected 
(200 eye discs per sample in three independent samples) and total RNA 
was prepared using TRIZOL (Invitrogen). First strand cDNA was generated 
and hybridized to GeneChip  Drosophila genome arrays (Affymetrix) by the 
Massachusetts General Hospital Cancer Center microarray core. Data were 
analyzed using Microarray Suite 5.0 (Affymetrix). Nine pairwise compari-
sons were performed between wild-type and  Tsc1 samples to calculate 
mean fold changes. Excel (Microsoft) was used to perform a  t test to calcu-
late signifi cant changes (P  < 0.05) in gene expression levels.  FOXO GOF 
microarray experiments have been described previously ( Puig et al. , 2003 ; 
 Gershman et al. , 2007 ). Overlap between  Tsc1 LOF and FOXO GOF micro-
arrays was performed using Excel (Microsoft). Measurement of signifi cance 
of overlap between microarrays was determined using hypergeometric dis-
tribution calculation. 
 Immunohistochemistry and microscopy 
 Antibodies used were anti-FOXO ( Puig et al., 2003 ), anti –  -galactosidase 
(Sigma-Aldrich), and anti – mouse and anti – rabbit Alexa fl uor secondary 
antibodies (Invitrogen). The nuclear dye used was Topro-3 (Invitrogen). 
Confocal microscopy was performed on a confocal microscope (SP2) using 
software (both from Leica). Images were captured using a 20 × NA 0.5 lens 
or a 40 × NA 1.25 oil immersion lens (both from Leica) at room temperature. 
Scanning electron microscopy was performed according to standard proto-
cols using a fi eld emission scanning electron microscope (XL30 FEG; Philips; 
 Bennett and Harvey, 2006 ). Any brightness or contrast adjustments were 
performed using Photoshop (Adobe). 
 Northern analysis 
 Total RNA was prepared from primary litter-matched wild-type or  TSC2 
MEFs (provided by D. Kwiatkowski, Brigham and Women ’ s Hospital, Boston, 
MA) using RNA STAT-60 (Tel-Test Inc.). 15   g RNA per lane was loaded 
and probed with the indicated  32 P-labeled cDNA probes as described 
previously ( Sofer et al., 2005 ). Probes were isolated by RT-PCR from 
embryonic day 9.5 mouse embryo RNA. 
 QPCR 
 RNA was extracted from third instar larval eye imaginal discs or S2 cells 
using TRIZOL, and fi rst strand cDNA was produced with a Superscript II 
kit (Invitrogen). QPCR reactions were analyzed on a sequence detection 
system (ABI Prism 7000; Applied Biosystems) using SYBR green reagents. 
To demonstrate that these expression changes were a specifi c 
consequence of  Tsc2 loss, we reconstituted  Tsc2 expression 
in  Tsc2  null cells, which substantially suppressed mammalian 
TOR activity and expression of these genes (unpublished data). 
Interestingly, expression of  phosphoenolpyruvate carboxy kinase 
and  4E-BP1 / 2 was not altered between wild-type and  Tsc2 cells 
(unpublished data), which might refl ect tissue- or species-specifi c 
differences in the transcriptome of  D. melanogaster epithelial 
cells and MEFs. 
 To determine whether the mode of transcription of these 
genes was also conserved in mammals, we analyzed expression 
of the  scy homologue  REDD1 . Like  scy , mammalian  REDD1 
orthologues possess a putative consensus FRE within their proxi-
mal promoters ( Furuyama et al., 2000 ). Cotransfection of a ver-
sion of FOXO that is insensitive to phosphorylation-dependent 
inhibition by Akt (TM-FKHRL-1) induced robust activation of 
a mouse  REDD1 reporter construct in primary MEFs ( Fig. 5 C ). 
To determine whether induction was mediated through the iden-
tifi ed FRE, we created a mutant reporter lacking this sequence. 
Deletion of the  REDD1 FRE consistently reduced FOXO-
mediated induction of the  REDD1 promoter ( Fig. 5 C ). Finally, to 
directly assess whether FOXO-dependent transcription was acti-
vated in mammalian cells lacking  Tsc2 , we examined activity of 
the  REDD1 promoter reporter or the corresponding mutant FRE 
reporter in wild-type and  Tsc2 MEFs. As predicted, the wild-type 
 REDD1 promoter exhibited robust activation in  Tsc2 cells com-
pared with wild-type cells, and this activation was substantially 
reduced by deletion of the FRE ( Fig. 5 D ). Together, these fi nd-
ings provide evidence that transcriptional changes resulting from 
 Tsc1/Tsc2 defi ciency are conserved in diverse species. 
 Here, we report identifi cation of an evolutionary conserved 
transcriptional program important for restricting tissue overgrowth 
driven by excessive activation of the TOR pathway. The FOXO 
tran scription factor plays a key role in this transcriptional response, 
likely by stimulating expression of several growth inhibitory genes. 
 Figure 5.  TOR pathway – driven transcriptional changes are conserved in 
eukaryotes. (A) Northern analysis of the  hsp27 , PSPH , REDD1 , REDD2 , and 
 GAPDH genes in primary  Tsc2 (  /  ) or wild-type littermate control (+/+) 
MEFs. (B) Schematic representation of the FRE in the  REDD1 promoter. 
(C) Luciferase assay ( n  = 4) measuring transcriptional activity of either wild-
type (WT) or FRE mutant (mtFRE)  REDD1 promoters in primary MEFs express-
ing either vector alone (Vector) or FOXO GOF (FOXO). (D) Transcriptional 
activity of the  REDD1 wild type or FRE mutant promoter in wild-type (wt) 
or  Tsc2 MEFs ( n  = 6). Error bars represent standard deviation. 
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